Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Other Non-Current Liabilities (2020 - 2023)

Rapid Therapeutic Science Laboratories' Other Non-Current Liabilities history spans 3 years, with the latest figure at $2.4 million for Q2 2023.

  • For Q2 2023, Other Non-Current Liabilities changed N/A year-over-year to $2.4 million; the TTM value through Jun 2023 reached $2.4 million, changed N/A, while the annual FY2022 figure was $2.4 million, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q2 2023 was $2.4 million at Rapid Therapeutic Science Laboratories, roughly flat from $2.4 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $2.4 million in Q3 2022 and bottomed at $44952.0 in Q2 2020.
  • The 3-year median for Other Non-Current Liabilities is $2.4 million (2022), against an average of $1.6 million.